Cresset Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$209K Buy
+6,954
New +$224K ﹤0.01% 1449
2025
Q1
Sell
-27,351
Closed -$603K 1851
2024
Q4
$603K Sell
27,351
-3,261
-11% -$59.3K ﹤0.01% 998
2024
Q3
$552K Buy
30,612
+2,849
+10% +$49.9K ﹤0.01% 1465
2024
Q2
$451K Buy
27,763
+6,804
+32% +$105K ﹤0.01% 1493
2024
Q1
$296K Buy
20,959
+2,970
+17% +$37.4K ﹤0.01% 1592
2023
Q4
$188K Sell
17,989
-416
-2% -$3.88K ﹤0.01% 1705
2023
Q3
$188K Buy
18,405
+6,294
+52% +$58.6K ﹤0.01% 1643
2023
Q2
$91.2K Buy
+12,111
New +$98.2K ﹤0.01% 1817
2023
Q1
Sell
-20,691
Closed -$189K 864
2022
Q4
$189K Buy
20,691
+392
+2% +$3.42K ﹤0.01% 644
2022
Q3
$164K Buy
20,299
+70
+0.3% +$619 ﹤0.01% 811
2022
Q2
$150K Sell
20,229
-1,304
-6% -$11.4K ﹤0.01% 860
2022
Q1
$202K Sell
21,533
-3,233
-13% -$27K ﹤0.01% 912
2021
Q4
$198K Buy
24,766
+958
+4% +$8.65K ﹤0.01% 1052
2021
Q3
$232K Buy
23,808
+1,602
+7% +$15K ﹤0.01% 964
2021
Q2
$220K Sell
22,206
-258
-1% -$2.73K ﹤0.01% 909
2021
Q1
$260K Buy
22,464
+1,850
+9% +$21.2K ﹤0.01% 743
2020
Q4
$199K Buy
20,614
+583
+3% +$5.58K ﹤0.01% 731
2020
Q3
$181K Hold
20,031
﹤0.01% 659
2020
Q2
$247K Buy
20,031
+1,449
+8% +$16.4K 0.01% 535
2020
Q1
$167K Buy
18,582
+219
+1% +$2.24K 0.01% 526
2019
Q4
$180K Sell
18,363
-501
-3% -$4.47K ﹤0.01% 571
2019
Q3
$130K Buy
18,864
+63
+0.3% +$483 ﹤0.01% 516
2019
Q2
$174K Sell
18,801
-524
-3% -$6.32K 0.01% 455
2019
Q1
$303K Buy
19,325
+18,813
+3,674% +$332K 0.01% 271
2018
Q4
$8K Buy
+512
New +$10.5K ﹤0.01% 915

Other funds holding TEVA